Ecopipam

From Self-sufficiency
Jump to: navigation, search
Ecopipam
File:Ecopipam structure.png
Systematic (IUPAC) name
(-)-trans-6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H-benzo[d]naptho-(2,1-b)azepine
Identifiers
CAS Number 112108-01-7
ATC code none
PubChem CID 107930
Chemical data
Formula C19H20ClNO
Molar mass 313.821 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Ecopipam (SCH-39166) is a synthetic benzazepine derivative drug that acts as a selective dopamine D1/D5 receptor antagonist, with little affinity for either dopamine D2-like or 5-HT2 receptors.[1] It has sedative, antipsychotic and anorectic effects, and was researched for human use although never approved for medical prescription, mainly because of side effects such as depression and anxiety.[2][3]

Synthesis

500px

Hou, D; Schumacher, D (2001). "The selection of a commercial route for the D1 antagonist Sch-39166". Current opinion in drug discovery & development. 4 (6): 792–9. PMID 11899619. 

Clinical Trials

Ecopipam is currently being used in a clinical trial conducted by the biotechnology company Psyadon for the treatment of Lesch-Nyhan Syndrome.[4]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />
  1. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  2. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  3. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  4. http://www.psyadonrx.com/ongoingclinicaltrials.html